Documente Academic
Documente Profesional
Documente Cultură
LATEST NEWS Betting on three themes to invest in the long run: Sumeet Nagar,
Stock Price Quotes Malabar Investments
Home Markets Stocks IPOs/FPOs Market Stats Market Moguls Expert View Technicals Commodities Forex Mobile Apps More
News Live Blog Trends Recos Earnings ETMarkets Podcast Market Paathshala Announcements Policy Market Calendar Stock Price Quotes
ET Home Markets Stocks Stock Price Quotes Search for New s, Stock Quotes & NAV's
NEWS JUST IN Betting on three themes to invest in the long run: Sumeet Nagar, M alabar Investments
New
Sharon Bio-Medicine Ltd. ENG
Summary
LIVE
NSE BSE Add to Watchlist | Set Alerts
15:48 | 31-03-2017
Today's Change Open Prev. Close
Charts 8.05 0.00 (0.00% )
Volume
132,912 8.05 8.05
VWAP: 8.05 Bid 8.05(2500) Offer 0.00(0)
Day's Trend
Mkt Cap ( Cr.) 96.1 Face Value () 2
News
P/E (x) -0.2 EPS-TTM (Rs.) -40.34
P/B (x) -0.49 BV/share () -16.41
Div_ Yield (%) 0 52Wk L/H 8.00 / 14.40
Results 8.00 8.10
BETA 0.61
Returns
Compare
Share
Holding
Insights: Events| Recos| Updates| News| Speed Tec hnic al Chart Provider : ChartIQ LLC
View community Outlook >> In the 50-share pack, 26 stocks were trading in the green, while
25 were in the red.
Hi undefined, share your view on Sharon Bio-Medicine
Sensex down; Future Lifestyle, Technocraft at fresh 52-
week high | News
Convert w ebpages or entire w ebsites to PDF - Use PDFmyURL!
Post as Guest 31 Mar 2017, 01:47PM IST
Login to Post
New User? Join Now Benchmark NSE Nifty index was down 14.25 points at 9,159.50
following mixed Asian cues.
Be the first one to post on Sharon Bio-Medicine Ltd.
Market rises; SBI, RIL among most active stocks in terms
of value on NSE | News
28 Mar 2017, 01:38PM IST
View Detailed Financials: Profit and Loss Cash Flows Balance Sheet Quarterly Results Half Year results Capital Structure
Sharon Bio-Med 8.05 0.00 -0.62 -9.55 -10.56 -28.76 -80.86 -77.48
Parenteral Drug 27.00 -1.82 -4.42 -5.43 29.19 -33.25 -9.70 -73.72
Sterling Bio 4.30 2.38 8.86 -1.15 21.13 6.17 -49.71 -55.44
Venus Remedies 97.65 0.05 -0.56 -4.26 2.36 8.92 -59.81 -40.31
Kilitch Drug 45.55 -0.22 -3.70 -2.04 22.94 24.28 137.86 -25.27
Bafna Pharma 29.60 -1.82 -1.99 -3.58 4.04 -2.15 62.64 0.00
Wanbury Ltd 57.90 2.84 12.32 -3.58 -1.36 22.15 146.38 189.50
Jagsonpal Pharm 38.00 0.53 0.26 -2.81 10.30 12.26 280.00 194.57
Alpa Labs 40.90 1.36 -0.12 -1.80 34.10 8.20 0.00 367.43
Bal Pharma 87.15 -0.85 -2.13 -8.98 -3.22 -17.08 177.55 378.85
Lyka Labs 54.60 0.28 -2.50 -12.43 4.50 -32.00 430.10 425.00
Top Loser for the period amongst the peers Top Gainer for the period amongst the peers
View Details: Historical Prices Dividends Splits Bonus Rights IPO Info
Better performer than its peers on this ratio Average performer than its peers on this ratio Underperformer than its peers on this ratio
Sharon Bio-Medicine Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed 253.45 Cr to Sales Value (100.00 % of Total
Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-03-2016, the company has reported a Consolidated sales of 35.77 Cr., down -65.83 from last quarter Sales of 104.69 Cr.
and unchanged .00 from last year same quarter Sales of Cr. Company has reported net profit after tax of -153.73 Cr. in latest quarter.
The companys CEO is Ms.Savita Satish Gowda. It's Board of Directors include Dr.Nivedita Patil, Mr.Harish Palecanda, Mr.Lalit Misra, Ms.Deepali
Bhatia, Ms.Savita Satish Gowda, Ms.Deepali Bhatia. Company has its registered office at Plot No.W-34, , W-34/1 MIDC, , Taloja, Raigad District,
410208, Maharashtra. Company has Shyam C Agrawal & Co. as its auditors. As on 31-12-2016, the company has a total of 118,935,700 shares
outstanding.
View Details: Chairman's Speech Company History Directors Report Background information Company Management Listing Information Finished
Convert w ebpages or entire w ebsites to PDF - Use PDFmyURL!
Products Board Meetings AGM/EGM
Quick Links
Sharon Bio-Medicine . Quick Links Markets Quick Links More from markets
Company Home Historical Prices Profit and Loss Daily Gainers Daily Losers
ET Markets Home
Cash Flow Statement Balance Sheet Account Most Active - Volume Most Active - Value
Stocks Home
Half Yearly Results Nine Monthly Results Quarterly Results NSE - All Indices Live Announcements
Market Live
Capital Structure Shareholding Pattern Yearly Results New 52Wk High New 52Wk Low
IPO/FPO/Rights Issue
Chairman's Speech Finished Products Directors Report Near 52Wk High Near 52Wk Low
Views and Recommendations
Company History Background Company Only Buyers Only Sellers
Technical Charts
Locations Information Management FII Activity MF Activity
Portfolio
Dividends Board Meetings Listing Information Weekly Gainers Weekly Losers
ET 500 Companies
Splits Bonus AGM/EGM Monthly Gainers Monthly Losers
Quarterly Results (Earnings)
Competitors IPO Information Rights Sensex Constituents Nifty Constituents
News Fall from Day's High Up from Day's Low View Complete Site Map
Date Sources:Liv e BSE and NSE Quotes Serv ice: TickerPlant | Corporate Data, F&O Data & Historical price v olume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, y ou agree to the Terms of Serv ice and Priv acy Policy .
Other Times Group news sites Living and entertainment Hot on the Web Services
Times of India | Timescity | iDiva | Zoom | BSE Sensex | Gold rate today ads2book | Gadgetsnow | Free Business Listings
| Mumbai Mirror Luxpresso | Gaana | Happytrips | Sensex | Gold rate Simplymarry | Astrospeak | Timesjobs | Magicbricks | Zigw heels | Timesdeal |
Times Now | Indiatimes Cricbuzz | Get Smartapp Income Tax Slabs | Income Tax dineout | Filmipop | Remit2india | Gaana | Greetzap | Techradar | Alivear |
| calculator Google Play
| Lifehacker Networking RBI Monetary Policy
Gizmodo | Eisamay | IGN India
NavGujarat Samay itimes | MensXP.com
About us / Advertise w ith us / Terms of Use & Grievance Redressal / Privacy Policy / Feedback / Sitemap / Code of Ethics / / Disclaimer Copyright 2017 Bennett, Coleman & Co. Ltd. All rights reserved.